跳至主要内容
临床试验/CTRI/2021/09/036781
CTRI/2021/09/036781已完成未知

Assessing Efficacy and Applicability of Intravenous Water Dissolved Silver Nanoparticles as a Novel Adjuvant in the Treatment of Severe SARS CoV2 Identified Pneumonia in Elderly patients ââ?¬â?? An Investigator Initiated Study (IIS).

Dr Subhasish Sarkar0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. RT-PCR Confirmed COVID 19 patients of either sex
  • 2. Age greater than 18 years
  • 3. EWS score 5 and above
  • 4. Clinically diagnosed moderately severe and severe pneumonia
  • 5. Willing to participate in the trial.

排除标准

  • 1. Patients with EWS score below 5
  • 2. Not Willing to participate in the trial

研究者

发起方
Dr Subhasish Sarkar

相似试验